Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
959.01B
Market cap959.01B
Price-Earnings ratio
36.77
Price-Earnings ratio36.77
Dividend yield
0.61%
Dividend yield0.61%
Average volume
3.14M
Average volume3.14M
High today
$1,037.75
High today$1,037.75
Low today
$1,003.69
Low today$1,003.69
Open price
$1,027.38
Open price$1,027.38
Volume
3.00M
Volume3.00M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

Eli Lilly(LLY) stock is priced at $1,015.20, giving the company a market capitalization of 959.01B. It carries a P/E multiple of 36.77 and pays a dividend yield of 61.0%.

On 2026-05-20, Eli Lilly(LLY) stock traded between a low of $1,003.69 and a high of $1,037.75. Shares are currently priced at $1,015.20, which is +1.1% above the low and -2.2% below the high.

The Eli Lilly(LLY)'s current trading volume is 3M, compared to an average daily volume of 3.14M.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,133.95 and a 52-week low of $623.78.

LLY News

CNBC 8h
Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme - CNBC

...

Eli Lilly accuses church bishops, businessmen of fraud in Trulicity drug rebate scheme - CNBC
TipRanks 8h
Eli Lilly Acquires Engage Biologics for $202 Million

U.S. pharmaceutical company Eli Lilly (LLY) has acquired Engage Biologics for $202 million in cash. Start a conversation with TipRanks’ trusted, data-backed in...

Benzinga 1d
Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

Trump's Eli Lilly Purchases Coincided With GLP-1 Policy Developments Citing disclosure forms signed by Trump, KFF Health News reported seven purchases of Eli Li...

Trump's Stock Picks Perfectly Timed With New Medicare Rules: Report

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
12.1%
Sell
3%

More LLY News

TipRanks 1d
Eli Lilly Completes Key Olomorasib Drug Interaction Study, Clarifying Next Steps for KRAS Pipeline

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper...

24/7 Wall St. 1d
If You Hold This Healthcare ETF, You're Losing Big

If You Hold This Healthcare ETF, You’re Losing Big By Omor Ibne Ehsan Published May 19, 11:12AM EDT Quick Read Fidelity MSCI Health Care ETF (FHLC) is down 5%...

If You Hold This Healthcare ETF, You're Losing Big
TipRanks 1d
President Trump Bought Eli Lilly Stock as Government Approved Weight-Loss Pill

U.S. President Donald Trump bought $680,000 of Eli Lilly (LLY) stock around the time that the U.S. Food and Drug Administration (FDA) approved the company’s new...

Nasdaq 2d
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party

Key Points There is a need for more weight loss drug options, including oral pills. Viking Therapeutics is working on a promising one, though tolerability mig...

Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics' Pill Could Crash the Weight-Loss Party
The Motley Fool 2d
Eli Lilly Stock: Next Stop $2,000?

It's been a volatile year for Eli Lilly (LLY 1.61%). The company's shares trended lower through the end of April, dropping well below $900. However, the drugmak...

Eli Lilly Stock: Next Stop $2,000?
24/7 Wall St. 2d
Three Biotechs That Are Top Takeover Targets

Three Biotechs That Are Top Takeover Targets By Alex Sirois Published May 18, 1:55PM EDT Quick Read Viking Therapeutics (VKTX) has a dual GLP-1/GIP agonist in...

Three Biotechs That Are Top Takeover Targets
Benzinga 2d
Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

• Eli Lilly stock is trending lower. Why is LLY stock trading lower? The Bloomberg report on Monday noted that the justices issued the decision without comment,...

Supreme Court Rejects Eli Lilly Appeal In Medicaid Fraud Case

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.